AI assistant
Sending…
Olema Pharmaceuticals, Inc. — Director's Dealing 2021
Apr 7, 2021
32591_dirs_2021-04-06_dfd25a43-f155-4da3-964f-9adaca543ab0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Olema Pharmaceuticals, Inc. (OLMA)
CIK: 0001750284
Period of Report: 2021-04-05
Reporting Person: Larson Yi (N/A)
More from Olema Pharmaceuticals, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Mar 20
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 13